Revenue by Geography
Rest of World Revenue
+0.68%
+7.01%
Other North American Operations (NAO) Revenue
-0.35%
-3.49%
Revenue
Total Obesity Care Revenue
+1.09%
+11.47%
Rare Disease Revenue
+1.32%
+13.96%
Victoza Revenue
+2.14%
+23.55%
Ozempic Revenue
-1.8%
-16.61%
Other Diabetes Care Revenue
-1.01%
-9.65%
Rybelsus Revenue
+0.93%
+9.71%
EBIT
Diabetes & Obesity Care Operating Profit
-0.04%
-0.38%
Rare Disease Operating Profit
-1.39%
-13.04%
